Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product recall alert for ketamine anaesthetic
A batch of Anesketin 100 mg/ml solution for injection has been recalled owing to vial closure integrity.

Dechra Ltd initiates Class 1 recall for a single batch of Anesketin solution for injection.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for Anesketin 100 mg/ml solution for injection manufactured by Dechra Ltd.

In a news release, the VMD writes: 'We wish to make wholesalers and veterinary surgeons aware that Dechra Ltd has initiated a Class I recall to veterinary level with immediate effect for batch 140461 of Anesketin 100 mg/ml solution for injection for dogs, cats and horses.

'The reason for the recall is a compromised closure of the vials. Dechra Ltd is contacting wholesale dealers and veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.'

Further information about the recall is available from Dechra's UK Customer Services Team on 01939 211200.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.